NZ202890A - Heterocyclic substituted diester derivatives and pharmaceutical compositions - Google Patents
Heterocyclic substituted diester derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ202890A NZ202890A NZ202890A NZ20289082A NZ202890A NZ 202890 A NZ202890 A NZ 202890A NZ 202890 A NZ202890 A NZ 202890A NZ 20289082 A NZ20289082 A NZ 20289082A NZ 202890 A NZ202890 A NZ 202890A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- ester
- pharmaceutically acceptable
- benzo
- diester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8138830 | 1981-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ202890A true NZ202890A (en) | 1985-10-11 |
Family
ID=10526823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ202890A NZ202890A (en) | 1981-12-23 | 1982-12-22 | Heterocyclic substituted diester derivatives and pharmaceutical compositions |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4520027A (forum.php) |
| EP (1) | EP0082665B1 (forum.php) |
| JP (1) | JPS58110567A (forum.php) |
| AT (1) | ATE14312T1 (forum.php) |
| AU (1) | AU553110B2 (forum.php) |
| CA (1) | CA1189510A (forum.php) |
| DD (1) | DD207712A5 (forum.php) |
| DE (1) | DE3264796D1 (forum.php) |
| DK (1) | DK542582A (forum.php) |
| ES (3) | ES8402557A1 (forum.php) |
| FI (1) | FI824336L (forum.php) |
| GR (1) | GR77042B (forum.php) |
| HU (1) | HU186650B (forum.php) |
| IE (1) | IE54220B1 (forum.php) |
| IL (1) | IL67416A0 (forum.php) |
| NO (1) | NO824335L (forum.php) |
| NZ (1) | NZ202890A (forum.php) |
| PT (1) | PT76020B (forum.php) |
| ZA (1) | ZA828850B (forum.php) |
| ZW (1) | ZW25182A1 (forum.php) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1261335A (en) * | 1984-08-29 | 1989-09-26 | Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee | Ethylenediamine monoamide derivatives |
| DK702188A (da) * | 1987-12-18 | 1989-06-19 | Glaxo Group Ltd | Ethanolaminderivater |
| ZA889405B (en) * | 1987-12-18 | 1989-12-27 | Glaxo Group Ltd | Ethanolamine derivatives |
| US5204482A (en) * | 1988-07-28 | 1993-04-20 | Hoffman-Laroche Inc. | Compounds for treating and preventing cognitive diseases and depression and methods of making same |
| EP0352581A3 (de) * | 1988-07-28 | 1990-07-04 | F. Hoffmann-La Roche Ag | Aethylendiaminmonoamid-Derivate |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US6075040A (en) * | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| ATE215369T1 (de) | 1996-09-05 | 2002-04-15 | Lilly Co Eli | Carbazolanaloge als selektive beta3-adrenergische agonisten |
| CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| FR2904317A1 (fr) * | 2006-07-27 | 2008-02-01 | Inst Nat Sante Rech Med | Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques |
| EP2085390A1 (en) | 2008-01-31 | 2009-08-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| GB1591618A (en) * | 1976-12-16 | 1981-06-24 | Ici Ltd | Esters of hydroxy amino amides |
| DE2861733D1 (en) * | 1977-08-16 | 1982-05-27 | Ici Plc | Anti-inflammatory 1-phenylethanolamine derivatives, pharmaceutical compositions thereof and processes for their manufacture |
| ATE798T1 (de) * | 1978-06-15 | 1982-04-15 | Imperial Chemical Industries Plc | Entzuendungshemmende 1-phe nyl-2-aminoaethanol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen zur oertlichen anwendung. |
| ZW9580A1 (en) * | 1979-05-21 | 1981-12-23 | Ici Ltd | 1-phenyl-2-aminoethanol derivatives |
-
1982
- 1982-11-25 IE IE2810/82A patent/IE54220B1/en not_active IP Right Cessation
- 1982-11-29 ZW ZW251/82A patent/ZW25182A1/xx unknown
- 1982-12-01 ZA ZA828850A patent/ZA828850B/xx unknown
- 1982-12-05 IL IL67416A patent/IL67416A0/xx unknown
- 1982-12-06 GR GR69998A patent/GR77042B/el unknown
- 1982-12-07 DK DK542582A patent/DK542582A/da not_active Application Discontinuation
- 1982-12-14 DE DE8282306680T patent/DE3264796D1/de not_active Expired
- 1982-12-14 EP EP82306680A patent/EP0082665B1/en not_active Expired
- 1982-12-14 AT AT82306680T patent/ATE14312T1/de not_active IP Right Cessation
- 1982-12-16 FI FI824336A patent/FI824336L/fi not_active Application Discontinuation
- 1982-12-20 HU HU824089A patent/HU186650B/hu unknown
- 1982-12-21 JP JP57223132A patent/JPS58110567A/ja active Pending
- 1982-12-22 NZ NZ202890A patent/NZ202890A/en unknown
- 1982-12-22 NO NO824335A patent/NO824335L/no unknown
- 1982-12-22 CA CA000418348A patent/CA1189510A/en not_active Expired
- 1982-12-22 PT PT76020A patent/PT76020B/pt unknown
- 1982-12-23 ES ES518527A patent/ES8402557A1/es not_active Expired
- 1982-12-23 DD DD82246482A patent/DD207712A5/de unknown
- 1982-12-23 US US06/452,804 patent/US4520027A/en not_active Expired - Fee Related
- 1982-12-23 AU AU91831/82A patent/AU553110B2/en not_active Ceased
-
1983
- 1983-08-16 ES ES524961A patent/ES524961A0/es active Granted
- 1983-08-16 ES ES524962A patent/ES8502965A1/es not_active Expired
-
1984
- 1984-12-20 US US06/684,253 patent/US4568691A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI824336A7 (fi) | 1983-06-24 |
| DD207712A5 (de) | 1984-03-14 |
| EP0082665A1 (en) | 1983-06-29 |
| ES8502964A1 (es) | 1985-02-01 |
| FI824336L (fi) | 1983-06-24 |
| PT76020B (en) | 1985-11-12 |
| IL67416A0 (en) | 1983-05-15 |
| GR77042B (forum.php) | 1984-09-04 |
| ATE14312T1 (de) | 1985-08-15 |
| ES524961A0 (es) | 1985-02-01 |
| EP0082665B1 (en) | 1985-07-17 |
| FI824336A0 (fi) | 1982-12-16 |
| HU186650B (en) | 1985-08-28 |
| NO824335L (no) | 1983-06-24 |
| US4568691A (en) | 1986-02-04 |
| IE822810L (en) | 1983-06-23 |
| ZA828850B (en) | 1984-03-28 |
| ES518527A0 (es) | 1984-02-01 |
| US4520027A (en) | 1985-05-28 |
| ES524962A0 (es) | 1985-02-01 |
| JPS58110567A (ja) | 1983-07-01 |
| ZW25182A1 (en) | 1984-06-20 |
| ES8402557A1 (es) | 1984-02-01 |
| DE3264796D1 (en) | 1985-08-22 |
| DK542582A (da) | 1983-06-24 |
| PT76020A (en) | 1983-01-01 |
| CA1189510A (en) | 1985-06-25 |
| ES8502965A1 (es) | 1985-02-01 |
| AU553110B2 (en) | 1986-07-03 |
| IE54220B1 (en) | 1989-07-19 |
| AU9183182A (en) | 1983-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69323732T2 (de) | Styrylderivate und verfahren zu ihrer herstellung | |
| US4520027A (en) | Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)alkylamino]ethyl) phenols | |
| AU756221B2 (en) | 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them | |
| US4621089A (en) | Pyrazolopyridine derivatives and their use in treating inflammation and allergic conditions | |
| JPS6333343A (ja) | ピリジル化合物製造用の新規中間体化合物 | |
| EP0122321A1 (en) | Hydroxybenzylamino derivatives as anti-inflammatory agents | |
| EP0377450B1 (en) | Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors | |
| DE69228142T2 (de) | Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung | |
| US4444772A (en) | Histamine H1 -antagonists | |
| EP0219308B1 (en) | 2-substituted quinolines | |
| KR0153527B1 (ko) | 아릴설폰아미드 및 이를 함유하는 약제학적 조성물 | |
| EP0334119B1 (en) | Compounds for inhibiting the biosynthesis of lipoxygenase-derived metabolites of arachidonic acid | |
| US5244917A (en) | Substituted naphthofurans as anti-inflammatory agents | |
| JPS6037116B2 (ja) | ２―置換オキサゾロピリジン | |
| US4863933A (en) | 3-hydroxypyridines | |
| KR100224153B1 (ko) | 6,9-비스[(2-아미노에틸)아미노]벤조[g]이소퀴놀린-5,10-디온및 이의 디말레산염의 개선된 합성 방법 | |
| US4282223A (en) | Isoquinoline derivatives, processes for their manufacture and their use for the manufacture of medicaments | |
| IE43659B1 (en) | New pyrazole derivatives and their manufacture and use | |
| JP2002516907A (ja) | 酸化窒素合成酵素阻害剤として縮合環置換基を含有する２−アミノピリジン | |
| US4716160A (en) | Certain 7-amino-pyrazolo[4,3-b]pyridines useful in treating inflammatory and allergic disorders | |
| US4914126A (en) | Aromatic amines | |
| US5006555A (en) | Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors | |
| AU2521501A (en) | 2-arylquinoline derivatives, preparation and therapeutic use thereof | |
| GB1591618A (en) | Esters of hydroxy amino amides |